Patheon to make diabetes drug; Sun's Caraco recalls 160,000 bottles of antidepressant;

> Caraco Pharmaceutical Laboratories, owned by Sun Pharmaceutical, is recalling more than 160,000 bottles of venlafaxine hydrochloride extended release tablets, a generic of Pfizer's ($PFE) Effexor XR. Story

> IBA Molecular North America will scale up manufacturing for cancer drug developer Actinium Pharmaceuticals' candidate to be used to prepare patients for hematopoietic stem cell transplant. Release

> Boston Therapeutics and partner Advance Pharmaceutical have turned to pharmaceutical services company Patheon to manufacture the diabetes drug they are developing. Release

> U.K.-based Onyx Scientific has completed a development and API manufacturing project with U.S.-based Neuronascent. Report

> The FDA has sent a warning letter to Blue Ridge Pharmacy and Compounding Center in Raleigh, NC. Warning Letter

And Finally... A botched execution has led a rights group to urge states with the death penalty to only use legally obtained drugs approved by the FDA, despite shortages of execution drugs. Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.